Kevin A. Buczkowski

2.5k total citations
4 papers, 71 citations indexed

About

Kevin A. Buczkowski is a scholar working on Molecular Biology, Dermatology and Oncology. According to data from OpenAlex, Kevin A. Buczkowski has authored 4 papers receiving a total of 71 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Dermatology and 2 papers in Oncology. Recurrent topics in Kevin A. Buczkowski's work include CAR-T cell therapy research (2 papers), Protein Degradation and Inhibitors (2 papers) and Cutaneous lymphoproliferative disorders research (2 papers). Kevin A. Buczkowski is often cited by papers focused on CAR-T cell therapy research (2 papers), Protein Degradation and Inhibitors (2 papers) and Cutaneous lymphoproliferative disorders research (2 papers). Kevin A. Buczkowski collaborates with scholars based in United States, France and Singapore. Kevin A. Buczkowski's co-authors include Peter S. Hammerman, Kwok‐Kin Wong, Ting Chen, Shengwu Liu, Yan Liu, Camilla L. Christensen, Steven N. Quayle, Yuyang Li, Shiwei Han and Hua Zhang and has published in prestigious journals such as Blood, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Kevin A. Buczkowski

4 papers receiving 71 citations

Peers

Countries citing papers authored by Kevin A. Buczkowski

Since Specialization

Citations

This map shows the geographic impact of Kevin A. Buczkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin A. Buczkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin A. Buczkowski more than expected).

Fields of papers citing papers by Kevin A. Buczkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin A. Buczkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin A. Buczkowski. The network helps show where Kevin A. Buczkowski may publish in the future.

Co-authorship network of co-authors of Kevin A. Buczkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin A. Buczkowski. A scholar is included among the top collaborators of Kevin A. Buczkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin A. Buczkowski. Kevin A. Buczkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

#	Work	Indexed citations
1	NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model 2018 ·Cancer Research ·Yan Liu, Yuyang Li, Shengwu Liu, Dennis O. Adeegbe, Camilla L. Christensen, Max M. Quinn, Ruben Dries, Shiwei Han, Kevin A. Buczkowski, Xiaoen Wang, Ting Chen, Peng Gao, Hua Zhang, Fei Li, Peter S. Hammerman, James E. Bradner, Steven N. Quayle, Kwok‐Kin Wong	40
2	Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Harbors Frequent Splicesosome Mutations That Cause Aberrant RNA Splicing Affecting Genes Critical in pDC Differentiation and Function 2016 ·Blood ·Katsuhiro Togami, Vikas Madan, Jia Li, Alexandra–Chloé Villani, Siranush Sarkizova, Mahmoud Ghandi, Kevin A. Buczkowski, Yvonne Li, Sabeha Biichlé, Fanny Angelot‐Delettre, Michael Seiler, Silvia Buonamici, Justin Taylor, Omar Abdel‐Wahab, Peter S. Hammerman, Nir Hacohen, Henry Yang, Francine Garnache‐Ottou, H. Phillip Koeffler, Andrew A. Lane	5
3	NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination Therapy 2015 ·Molecular Cancer Therapeutics ·Chunxiao Xu, Kevin A. Buczkowski, (unknown), Hajime Asahina, Ellen M. Beauchamp, Hideki Terai, Yvonne Y. Li, Matthew Meyerson, Kwok‐Kin Wong, Peter S. Hammerman	24
4	Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patient-Derived Xenografts Are Faithful Genomic and Phenotypic Models of Primary Leukemia and Respond to the IL3 Receptor Targeting Agent SL-401 In Vivo 2015 ·Blood ·Amanda L. Christie, Yvonne Li, Katsuhiro Togami, Mahmoud Ghandi, Alexandra Christodoulou, Kevin A. Buczkowski, Fanny Angelot‐Delettre, Sabeha Biichlé, Janice Chen, Christopher Brooks, David M. Weinstock, Francine Garnache‐Ottou, Peter S. Hammerman, Andrew A. Lane	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact